RMTI earnings call for the period ending June 30, 2019.
News & Analysis: Rockwell Medical
The price of Rockwell Medical's latest stock offering wasn't right for investors.
RMTI earnings call for the period ending March 31, 2019.
Find out what caused these stocks to miss out on a good market day.
The pharma continues to struggle. Here's how things could get better.
There's a potential for a huge profit here -- but not many investors are buying it.
The company's success depends heavily on its ability to get its iron replacement drug Triferic on a more profitable course.
Poor sales for its recently launched Triceric have investors heading for the exit.
Will new iron-replacement drug Triferic live up to its potential in the new year?
Wall Street analysts downplay the potential for Rockwell Medical's Triferic.